适应性血液动力内皮细胞用于器官生成和瘤生成
Brisa Palikuqi1, Duc-Huy T Nguyen1, Ge Li1
1Division of Regenerative Medicine, Ansary Stem Cell Institute, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Nature
|September 10, 2020
概括
在成熟的内皮细胞中,ETS变异转录因子2 (ETV2) 的过渡性重新激活会产生适应性的血管网络. 这些重置血管内皮细胞 (R-VEC) 能够进行器官血管化和组织修复.
科学领域:
- 血管生物学和再生医学
- 内皮细胞生物学和组织工程
背景情况:
- 成熟的内皮细胞在培养中丧失了组织特异性血管化的适应性.
- 器官的发育和再生依赖于特定组织的内皮细胞特征.
研究的目的:
- 确定ETS变异转录因子2 (ETV2) 的短暂重新激活是否可以恢复成熟的人体内皮细胞的适应性.
- 开发一种可扩展的器官血管化平台,并研究内皮细胞与细胞的相互作用.
主要方法:
- 培养成熟的人体内皮细胞在拉米尼-菌素类型IV原基质 (LEC) 中.
- 暂时重新激活ETV2以产生恢复的血管内皮细胞 (R-VEC).
- 评估微流体室中的R-VEC自我组装和小鼠体内植入.
- 使用R-VEC在一个新的"器官-血管网"平台与器官和瘤一起培养.
- 使用单细胞RNA测序和表观遗传特征分析R-VEC行为.
主要成果:
- ETV2的重新激活将内皮细胞"重置"为血管生成的R-VEC,形成可 perfus 的血管.
- 在3D矩阵中,R-VEC自我组装成稳定的多层血管网络,并在体内与宿主循环进行解剖.
- 器官对血管网络使人类胰腺小岛,脱细胞化肠道和结肠器官的功能血管化成为可能.
- R-VEC 建立了一个适应性血管,以特定组织的方式符合器官和瘤.
结论:
- 过时的ETV2重新激活使内皮细胞复原,使其能够进行器官型血管化.
- 器官对血管网络平台为研究器官对细胞交叉声提供了一个生理模型.
- 这种方法具有治疗器官修复和向癌症治疗的潜力.
更多相关视频
04:23Directed Differentiation of Hemogenic Endothelial Cells from Human Pluripotent Stem Cells
Published on: March 31, 2021
2.5K
09:24Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells
Published on: September 18, 2019
10.4K
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
